Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2009-06-22 16:08:36 UTC |
---|
Update Date | 2014-12-24 20:24:38 UTC |
---|
Accession Number | T3D1790 |
---|
Identification |
---|
Common Name | 5-Bromouracil |
---|
Class | Small Molecule |
---|
Description | 5-bromouracil is brominated derivative of uracil that acts as an antimetabolite or base analog, substituting for thymine in DNA. It can induce DNA mutations in the same way as 2-aminopurine. It is used mainly as an experimental mutagen, but its deoxyriboside derivative (5-bromo-2-deoxyuridine) is used to treat neoplasms. 5-bromouracil can be generated naturally, within the body, from uracil by either eosinophil peroxidase or myeloperoxidase. These enzymes preferentially brominate uracil at plasma concentrations of bromine and under moderately acidic conditions. |
---|
Compound Type | - Amide
- Bromide Compound
- Industrial/Workplace Toxin
- Lachrymator
- Organic Compound
- Organobromide
- Synthetic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Synonym | 1,2,3,4-tetrahydro-5-bromo-2,4-pyrimidinedione | 2,4-Pyrimidinedione, 1,2,3,4-tetrahydro-5-bromo | 5-Bromo-2,4(1H,3H)-pyrimidinedione | 5-Bromo-2,4-dihydroxypyrimidine | 5-Bromo-2,4-pyrimidinediol | 5-bromopyrimidine-2,4(1H,3H)-dione | Bromouracil | Bromuracil | C4H3BrN2O2 | Uracil, 5-bromo- | URB |
|
---|
Chemical Formula | C4H3BrN2O2 |
---|
Average Molecular Mass | 190.983 g/mol |
---|
Monoisotopic Mass | 189.938 g/mol |
---|
CAS Registry Number | 51-20-7 |
---|
IUPAC Name | 5-bromo-1,2,3,4-tetrahydropyrimidine-2,4-dione |
---|
Traditional Name | bromouracil |
---|
SMILES | BrC1=CNC(=O)NC1=O |
---|
InChI Identifier | InChI=1S/C4H3BrN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9) |
---|
InChI Key | InChIKey=LQLQRFGHAALLLE-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as halopyrimidines. These are aromatic compounds containing a halogen atom linked to a pyrimidine ring. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazines |
---|
Sub Class | Pyrimidines and pyrimidine derivatives |
---|
Direct Parent | Halopyrimidines |
---|
Alternative Parents | |
---|
Substituents | - Hydroxypyrimidine
- Halopyrimidine
- Aryl halide
- Aryl bromide
- Heteroaromatic compound
- Azacycle
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Organobromide
- Organohalogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | 310°C | Boiling Point | Not Available | Solubility | 0.815 mg/mL [GUNTHER,FA et al. (1968)] | LogP | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0006-0900000000-3a083d7a254f02ae1d66 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0006-0900000000-c7659146e2d62891c141 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-014j-5900000000-6c9736365d3f4619558f | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000l-6900000000-2859f1a95bc39decb00d | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0006-9100000000-0c7a53d2d2416a9c8564 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0006-9000000000-84558ca4912270154af2 | 2016-08-03 | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-0007-3900000000-c3f1f4cbe37bd2041f68 | 2014-09-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, DMSO-d6, experimental) | Not Available | 2014-09-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 15.09 MHz, DMSO-d6, experimental) | Not Available | 2014-09-23 | View Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Oral (4) ; inhalation (4) ; dermal (4) |
---|
Mechanism of Toxicity | Thymidine phosphorylase, a pyrimidine salvage enzyme, transforms 5-bromouracil to 5-bromodeoxyuridine, a mutagenic analogue of thymidine. Ultimately, 5-bromouracil acts on DNA. It induces a random DNA point mutation via base substitution. The base pair will change from an A-T to a G-C or from a G-C to an A-T after a number of replication cycles, depending on whether 5-BrU is within the DNA molecule or is an incoming base when it is enolized or ionized. 5-Bromouracil normally pairs with adenine. However, the proportion of 5-bromouracil in the enol tautomer is higher than that of thymine because the bromine atom is more electronegative than is a methyl group on the C-5 atom. Thus, the incorporation of 5-bromouracil is especially likely to cause altered base-pairing in a subsequent round of DNA replication. |
---|
Metabolism | 5-bromouracil is metabolized into 5-bromodeoxyuridine via thymidine phosphorylase. (4) |
---|
Toxicity Values | LD50: 1700 mg/kg (Rat, Intraperitoneal); LD50 1400 mg/kg (Mouse, Intraperitoneal) (1)
|
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not listed by IARC. May cause heritable genetic damage. |
---|
Uses/Sources | Laboratory chemical used as a mutagen in many mutagenesis experiments. |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | 5-bromouracil is a mutagen (causes mutations) and a carcinogen. It can cause respiratory tract irritation if inhaled, skin irritation if it contacts the skin and eye irritation if it contacts the eyes.
|
---|
Symptoms | 5-bromouracil can cause hypermotility, diarrhea, weight loss and possibly death if large amounts are repeatedly ingested.
|
---|
Treatment | EYES: irrigate opened eyes for several minutes under running water.
INGESTION: do not induce vomiting. Rinse mouth with water (never give anything by mouth to an unconscious person). Seek immediate medical advice.
SKIN: should be treated immediately by rinsing the affected parts in cold running water for at least 15 minutes, followed by thorough washing with soap and water. If necessary, the person should shower and change contaminated clothing and shoes, and then must seek medical attention.
INHALATION: supply fresh air. If required provide artificial respiration. |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | Not Available |
---|
PubChem Compound ID | 5802 |
---|
ChEMBL ID | CHEMBL144730 |
---|
ChemSpider ID | 5597 |
---|
KEGG ID | Not Available |
---|
UniProt ID | Not Available |
---|
OMIM ID | |
---|
ChEBI ID | 20552 |
---|
BioCyc ID | Not Available |
---|
CTD ID | D001976 |
---|
Stitch ID | 5-Bromouracil |
---|
PDB ID | Not Available |
---|
ACToR ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | T3D1790.pdf |
---|
General References | - Lewis RJ (1996). Sax's Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold.
- Golomb, BA (1999). A Review of the Scientific Literature As It Pertains to Gulf War Illnesses. Volume 2: Pyridostigmine Bromide. Washington, DC: RAND.
- Wikipedia. 5-Bromouracil. Last Updated 21 May 2009. [Link]
- International Programme on Chemical Safety (IPCS) INCHEM (1992). Poison Information Monograph for Bromine. [Link]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Not Available |
---|
Down-Regulated Genes | Not Available |
---|